Skip to main content
. 2022 Feb;8(2):a006200. doi: 10.1101/mcs.a006200

Figure 1.

Figure 1.

Catalyzing personalized medicine for all rare disease patients. This flywheel depicts the patient and family at the center of the rare diseases community's translational research and care activities, aimed at providing accurate diagnosis and counseling, effective and accessible therapies, and ultimately tailored care and prevention. Patients are partners in the process, strengthening the transdisciplinary team of basic and laboratory scientists, paramedical clinicians, and ethicists who unite expertise and efforts to catalyze this flywheel to leave no rare disease patient behind. We apply this model in the Emma Center for Personalized Medicine at Amsterdam UMC. (Copyright: Health2Media.)